文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

无创通气作为有创机械通气撤机策略:系统评价与贝叶斯Meta分析

Non-invasive ventilation as a strategy for weaning from invasive mechanical ventilation: a systematic review and Bayesian meta-analysis.
PubMed 文献 · Intensive Care Med · 2018-10-31
一句话结论在需要有创通气超过24小时的成人中,早期拔管转无创通气撤机策略较有创通气撤机降低医院内死亡率(OR 0.58,95% HDI 0.29-0.89),COPD患者获益最明显。

该系统评价与贝叶斯Meta分析纳入25项随机及半随机对照试验共1609例成人患者,比较早期拔管转无创通气(NIV)撤机与有创通气撤机策略。主要终点医院内死亡率在NIV撤机组更低(合并OR 0.58,95% HDI 0.29-0.89)。亚组分析显示COPD患者获益明显(OR 0.43,95% HDI 0.13-0.81),混合ICU人群效果不确定(OR 0.88,95% HDI 0.25-1.48)。NIV撤机缩短有创通气时间(SMD -1.34)和ICU住院时间(SMD -0.70),呼吸机相关性肺炎发生率更低,但未降低总住院时间或长期死亡率。

要点

  • 在需要有创通气超过24小时的成人中,NIV撤机策略较有创通气撤机降低医院内死亡率(合并OR 0.58,95% HDI 0.29-0.89)。
  • COPD患者从NIV撤机策略中获益最明显(合并OR 0.43,95% HDI 0.13-0.81),混合ICU人群效果不确定(OR 0.88,95% HDI 0.25-1.48)。
  • NIV撤机缩短有创通气时间(SMD -1.34,95% HDI -1.92至-0.77)和ICU住院时间(SMD -0.70,95% HDI -0.94至-0.46)。
  • NIV组呼吸机相关性肺炎(VAP)报告率更低,但NIV撤机未降低总住院时间或长期死亡率。
  • 纳入研究因实施偏倚和检测偏倚存在中至高质量偏倚风险,其他不良事件及健康相关生活质量数据不足。

适用人群与场景

  • 需要有创机械通气超过24小时的成人呼吸衰竭患者。
  • 纳入随机及半随机对照试验,比较NIV撤机与有创通气撤机策略。

处置流程与药物剂量

  • 撤机策略:早期拔管后转为无创通气(NIV),与继续有创通气撤机相比较。
  • 亚组:COPD患者获益更明显(合并OR 0.43,95% HDI 0.13-0.81);混合ICU人群效果不确定(合并OR 0.88,95% HDI 0.25-1.48)。

研究设计与关键结果

  • 系统评价与贝叶斯Meta分析纳入25项随机及半随机对照试验,共1609例成人患者。
  • 主要终点医院内死亡率:NIV撤机组低于有创通气撤机组(合并OR 0.58,95% HDI 0.29-0.89)。
  • COPD患者医院内死亡率:NIV撤机组低于对照组(合并OR 0.43,95% HDI 0.13-0.81)。
  • 混合ICU人群医院内死亡率:NIV撤机组与对照组无显著差异(合并OR 0.88,95% HDI 0.25-1.48)。
  • 有创通气时间:NIV撤机组缩短(SMD -1.34,95% HDI -1.92至-0.77)。
  • ICU住院时间:NIV撤机组缩短(SMD -0.70,95% HDI -0.94至-0.46)。
  • 呼吸机相关性肺炎(VAP)报告率:NIV组更低。
  • 总住院时间及长期死亡率:NIV撤机未降低;其他不良事件及健康相关生活质量数据不足。

证据类型、等级与局限

  • 证据类型:系统评价与贝叶斯Meta分析,纳入25项随机及半随机对照试验。
  • 偏倚风险:纳入研究因实施偏倚和检测偏倚存在中至高质量偏倚风险。
  • 局限:其他不良事件及健康相关生活质量数据不足。

对床旁实践的改变

  • 在需要有创通气超过24小时的成人中,NIV撤机策略可降低医院内死亡率、VAP发生率并缩短ICU住院时间,COPD患者获益最明显。
  • 混合ICU人群的获益不确定(合并OR 0.88,95% HDI 0.25-1.48)。
  • NIV撤机未降低总住院时间或长期死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: A systematic review and meta-analysis was conducted to answer the question 'In adults with respiratory failure requiring invasive ventilation for more than 24 h, does a weaning strategy with early extubation to non-invasive ventilation (NIV) compared to invasive ventilation weaning reduce all-cause hospital mortality?'

METHODS: We included randomised and quasi-randomised controlled trials that evaluated the use of non-invasive ventilation, compared to invasive ventilation, as a weaning strategy in adults mechanically ventilated for at least 24 h. The EMBASE, MEDLINE and Cochrane Central Register of Controlled Trials (CENTRAL) bibliographic databases were searched from inception to February 2018. Bayesian hierarchical models were used to perform the meta-analysis. The primary outcome was mortality at hospital discharge. Secondary outcomes included mortality (30, 60, 90 and 180 days), quality of life, duration of invasive ventilation, weaning failure, length of stay [intensive care unit (ICU) and hospital] and adverse events.

RESULTS: Twenty-five relevant studies involving 1609 patients were included in the quantitative analysis. Studies had moderate to high risk of bias due to risk of performance and detection bias. Mortality at hospital discharge was lower in the NIV weaning group compared to the invasive weaning group [pooled odds ratio (OR) 0.58, 95% highest density interval (HDI) 0.29-0.89]. Subgroup analyses showed lower pooled mortality at hospital discharge rates in NIV weaning than those in the control group in chronic obstructive pulmonary disease (COPD) patients (pooled OR 0.43, 95% HDI 0.13-0.81) and the effect is less certain in the mixed ICU population (pooled OR 0.88, 95% HDI 0.25-1.48). NIV weaning reduced the duration of invasive ventilation in patients [standardised mean difference (SMD) - 1.34, 95% HDI - 1.92 to - 0.77] and ICU length of stay (SMD - 0.70, 95% HDI - 0.94 to - 0.46). Reported rates of ventilator associated pneumonia (VAP) were lower in the NIV group. NIV weaning did not reduce overall hospital length of stay or long-term mortality. There were insufficient data to compare other adverse events and health-related quality of life.

CONCLUSIONS: The use of NIV in weaning from mechanical ventilation decreases hospital mortality, the incidence of VAP and ICU length of stay. NIV as a weaning strategy appears to be most beneficial in patients with COPD.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Yeung J, Couper K, Ryan EG, et al. Non-invasive ventilation as a strategy for weaning from invasive mechanical ventilation: a systematic review and Bayesian meta-analysis. Intensive Care Med. 2018. PMID: 30382306. doi:10.1007/s00134-018-5434-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。